Amunix: Sanofi to buy PE-backed Amunix Pharmaceuticals
Sanofi has agreed to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company.
Read full article »
Amunix is a California-based biotechnology company that develops and markets T-cell and cytokine therapies for the treatment of cancer.
Read more